A dietary supplementation with Urolithin A, a pomegranate metabolite, could help slow down certain aging processes by improving mitochondrial and cellular health in humans: this is the finding of a clinical trial published in the journal Nature Metabolism by EPFL spin-off Amazentis, in conjunction with EPFL and SIB Scientists in the Vital-IT Group who helped analyze the data.
Read more on the EPFL website and the Amazentis press release
Reference(s)
Andreux P A et al. The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nature metabolism.
